Parathyroid hormone induction of the osteocalcin gene: Requirement for an osteoblast-specific element 1 sequence in the promoter and involvement of multiple signaling pathways

Di Jiang, Renny T. Franceschi, Heidi Boules, Guozhi Xiao

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

Parathyroid hormone (PTH) is an important peptide hormone regulator of bone formation and osteoblast activity. However, its mechanism of action in bone cells is largely unknown. This study examined the effect of PTH on mouse osteocalcin gene expression in MC3T3-E1 preosteoblastic cells and primary cultures of bone marrow stromal cells. PTH increased the levels of osteocalcin mRNA 4-5-fold in both cell types. PTH also stimulated transcriptional activity of a 1.3-kb fragment of the mouse osteocalcin gene 2 (mOG2) promoter. Inhibitor studies revealed a requirement for protein kinase A, protein kinase C, and mitogen-activated protein kinase pathways in the PTH response. Deletion of the mOG2 promoter sequence from - 1316 to - 116 caused no loss in PTH responsiveness whereas deletion from -116 to -34 completely prevented PTH stimulation. Interestingly, this promoter region does not contain the RUNX2 binding site shown to be necessary for PTH responsiveness in other systems. Nuclear extracts from PTH-treated MC3T3-E1 cells exhibited increased binding to OSE1, a previously described osteoblast-specific enhancer in the mOG2 promoter. Furthermore, mutation of OSE1 in DNA transfection assays established the requirement for this element in the PTH response. Collectively, these studies establish that actions of PTH on the osteocalcin gene are mediated by multiple signaling pathways and require OSE1 and associated nuclear proteins.

Original languageEnglish (US)
Pages (from-to)5329-5337
Number of pages9
JournalJournal of Biological Chemistry
Volume279
Issue number7
DOIs
StatePublished - Feb 13 2004
Externally publishedYes

Fingerprint

Osteocalcin
Osteoblasts
Parathyroid Hormone
Genes
Bone
Primary Cell Culture
Peptide Hormones
Nuclear Proteins
Cyclic AMP-Dependent Protein Kinases
Mitogen-Activated Protein Kinases
Mesenchymal Stromal Cells
Genetic Promoter Regions
Osteogenesis
Gene expression
Protein Kinase C
Transfection
Assays
Binding Sites
Gene Expression
Bone and Bones

ASJC Scopus subject areas

  • Biochemistry

Cite this

Parathyroid hormone induction of the osteocalcin gene : Requirement for an osteoblast-specific element 1 sequence in the promoter and involvement of multiple signaling pathways. / Jiang, Di; Franceschi, Renny T.; Boules, Heidi; Xiao, Guozhi.

In: Journal of Biological Chemistry, Vol. 279, No. 7, 13.02.2004, p. 5329-5337.

Research output: Contribution to journalArticle

@article{d17d4b0d53204b40b9d3816ca6b3bee8,
title = "Parathyroid hormone induction of the osteocalcin gene: Requirement for an osteoblast-specific element 1 sequence in the promoter and involvement of multiple signaling pathways",
abstract = "Parathyroid hormone (PTH) is an important peptide hormone regulator of bone formation and osteoblast activity. However, its mechanism of action in bone cells is largely unknown. This study examined the effect of PTH on mouse osteocalcin gene expression in MC3T3-E1 preosteoblastic cells and primary cultures of bone marrow stromal cells. PTH increased the levels of osteocalcin mRNA 4-5-fold in both cell types. PTH also stimulated transcriptional activity of a 1.3-kb fragment of the mouse osteocalcin gene 2 (mOG2) promoter. Inhibitor studies revealed a requirement for protein kinase A, protein kinase C, and mitogen-activated protein kinase pathways in the PTH response. Deletion of the mOG2 promoter sequence from - 1316 to - 116 caused no loss in PTH responsiveness whereas deletion from -116 to -34 completely prevented PTH stimulation. Interestingly, this promoter region does not contain the RUNX2 binding site shown to be necessary for PTH responsiveness in other systems. Nuclear extracts from PTH-treated MC3T3-E1 cells exhibited increased binding to OSE1, a previously described osteoblast-specific enhancer in the mOG2 promoter. Furthermore, mutation of OSE1 in DNA transfection assays established the requirement for this element in the PTH response. Collectively, these studies establish that actions of PTH on the osteocalcin gene are mediated by multiple signaling pathways and require OSE1 and associated nuclear proteins.",
author = "Di Jiang and Franceschi, {Renny T.} and Heidi Boules and Guozhi Xiao",
year = "2004",
month = "2",
day = "13",
doi = "10.1074/jbc.M311547200",
language = "English (US)",
volume = "279",
pages = "5329--5337",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "7",

}

TY - JOUR

T1 - Parathyroid hormone induction of the osteocalcin gene

T2 - Requirement for an osteoblast-specific element 1 sequence in the promoter and involvement of multiple signaling pathways

AU - Jiang, Di

AU - Franceschi, Renny T.

AU - Boules, Heidi

AU - Xiao, Guozhi

PY - 2004/2/13

Y1 - 2004/2/13

N2 - Parathyroid hormone (PTH) is an important peptide hormone regulator of bone formation and osteoblast activity. However, its mechanism of action in bone cells is largely unknown. This study examined the effect of PTH on mouse osteocalcin gene expression in MC3T3-E1 preosteoblastic cells and primary cultures of bone marrow stromal cells. PTH increased the levels of osteocalcin mRNA 4-5-fold in both cell types. PTH also stimulated transcriptional activity of a 1.3-kb fragment of the mouse osteocalcin gene 2 (mOG2) promoter. Inhibitor studies revealed a requirement for protein kinase A, protein kinase C, and mitogen-activated protein kinase pathways in the PTH response. Deletion of the mOG2 promoter sequence from - 1316 to - 116 caused no loss in PTH responsiveness whereas deletion from -116 to -34 completely prevented PTH stimulation. Interestingly, this promoter region does not contain the RUNX2 binding site shown to be necessary for PTH responsiveness in other systems. Nuclear extracts from PTH-treated MC3T3-E1 cells exhibited increased binding to OSE1, a previously described osteoblast-specific enhancer in the mOG2 promoter. Furthermore, mutation of OSE1 in DNA transfection assays established the requirement for this element in the PTH response. Collectively, these studies establish that actions of PTH on the osteocalcin gene are mediated by multiple signaling pathways and require OSE1 and associated nuclear proteins.

AB - Parathyroid hormone (PTH) is an important peptide hormone regulator of bone formation and osteoblast activity. However, its mechanism of action in bone cells is largely unknown. This study examined the effect of PTH on mouse osteocalcin gene expression in MC3T3-E1 preosteoblastic cells and primary cultures of bone marrow stromal cells. PTH increased the levels of osteocalcin mRNA 4-5-fold in both cell types. PTH also stimulated transcriptional activity of a 1.3-kb fragment of the mouse osteocalcin gene 2 (mOG2) promoter. Inhibitor studies revealed a requirement for protein kinase A, protein kinase C, and mitogen-activated protein kinase pathways in the PTH response. Deletion of the mOG2 promoter sequence from - 1316 to - 116 caused no loss in PTH responsiveness whereas deletion from -116 to -34 completely prevented PTH stimulation. Interestingly, this promoter region does not contain the RUNX2 binding site shown to be necessary for PTH responsiveness in other systems. Nuclear extracts from PTH-treated MC3T3-E1 cells exhibited increased binding to OSE1, a previously described osteoblast-specific enhancer in the mOG2 promoter. Furthermore, mutation of OSE1 in DNA transfection assays established the requirement for this element in the PTH response. Collectively, these studies establish that actions of PTH on the osteocalcin gene are mediated by multiple signaling pathways and require OSE1 and associated nuclear proteins.

UR - http://www.scopus.com/inward/record.url?scp=1242339671&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1242339671&partnerID=8YFLogxK

U2 - 10.1074/jbc.M311547200

DO - 10.1074/jbc.M311547200

M3 - Article

C2 - 14634012

AN - SCOPUS:1242339671

VL - 279

SP - 5329

EP - 5337

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 7

ER -